Why physicians join our oncology community
Sermo’s oncology physician network provides practicing oncologists with a secure, peer-driven platform to discuss the latest in diagnostics, treatments, clinical trials, and groundbreaking research. Whether you’re a hospital-based consultant, hematologic oncologist, or actively engaged in clinical trials and patient communication, Sermo connects you to peers facing similar challenges—from FDA regulatory complexity to patient access barriers.
Earn money sharing your oncology expertise
Learn why surveys are worth it for oncologists and tackle topics such as:
- Surveys on CAR-T and end-of-life care
- Opinion polls on neoadjuvant therapies
- Research studies around managing chemotherapy side effects

Discover oncology drug insights
Get practical, peer-reviewed information on oncology treatments:
- Detailed safety profiles of oncology drugs
- Comparative efficacy assessments
- Real-world tolerability experiences
- FDA approval timelines and practical use cases

Explore oncology articles and case studies
Discover strategies and real-world advice based on insights from physicians on Sermo.
- Discussing clinical trials with oncology patients
- Showing empathy with oncology patients
- Barriers to cancer care and treatments
- Emerging cancer treatments

Hear from fellow oncology peers
Sermo became my ‘2nd Medical Home’! Thanks for being always here when I get up in the mornings -and obviously, thank you to the colleagues on Sermo
Going onto Sermo is one of the “highlights” of the day for me
I like the general awareness of issues and ability to think critically about different medical cases
Have no words! Since I’m a retired MD, Sermo has become such an important part of my daily life. Thanks to Sermo for being here at home — of so many Doctors around the world! Best wishes to you and every Sermoan in the team
Frequently asked questions
Sermo’s oncology community regularly shares updates and discussions around FDA approvals, trial outcomes, and post-marketing experiences with newly released cancer therapies.
Yes. Our drug ratings feature allows oncologists to review and compare cancer medications across efficacy, safety, tolerability, and accessibility — based on real-world experiences from practicing physicians.
Absolutely. Sermo members frequently share information and personal experiences related to clinical trial eligibility, patient recruitment challenges, and trial design. You can also participate in polls on emerging protocols and trial access.
Yes. Whether you work in private practice, academic medicine, or research institutions, Sermo provides a space to share your expertise and learn from others managing both clinical and translational challenges.
You’ll find case studies ranging from rare tumor presentations to complex multi-treatment scenarios, often covering decisions around immunotherapy, precision medicine, or managing end-of-life care.
Yes. Many discussions in the oncology network focus on how government legislation, insurance coverage, and cost pressures impact clinical decision-making and patient care.
Sermo enables real-time collaboration with oncology peers around the world. Post a case anonymously and receive input within hours—helping you make confident decisions when time and clarity matter most.
There are currently over 43,000 oncologists in the Sermo community.
Sermo complements these communities with real-time peer discussion, drug insight directories, and trending specialty polls.
Start your oncology journey on Sermo
Become part of a dynamic oncology physician network of over 43,000 members dedicated to improving patient outcomes and advancing cancer care through peer collaboration and expert insights.
